Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 566128

New dosimetric patient-based modelling of thyroid remnant stunning and ablation


Medvedec, Mario
New dosimetric patient-based modelling of thyroid remnant stunning and ablation // Abstract Book of the 57th Annual Meeting of The Society of Nuclear Medicine (SNM) ; u: The Journal of Nuclear Medicine 51 (2010) (S2) ; 1567 / Schelbert, Heinrich R. (ur.).
Reston: The Society of Nuclear Medicine, 2010. str. 319P-319P (poster, međunarodna recenzija, sažetak, znanstveni)


CROSBI ID: 566128 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
New dosimetric patient-based modelling of thyroid remnant stunning and ablation

Autori
Medvedec, Mario

Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni

Izvornik
Abstract Book of the 57th Annual Meeting of The Society of Nuclear Medicine (SNM) ; u: The Journal of Nuclear Medicine 51 (2010) (S2) ; 1567 / Schelbert, Heinrich R. - Reston : The Society of Nuclear Medicine, 2010, 319P-319P

Skup
Annual Meeting of The Society of Nuclear Medicine (57 ; 2010)

Mjesto i datum
Salt Lake City, Utah, SAD, 05.-09.06.2010

Vrsta sudjelovanja
Poster

Vrsta recenzije
Međunarodna recenzija

Ključne riječi
thyroid cancer; dosimetry; thyroid stunning; thyroid remnant ablation

Sažetak
This work describes an effort to quantitatively investigate the effect of thyroid stunning and to derive a novel in-vivo dosimetric model as a useful guidance for clinical practice of radioiodine ablation in patients with well-differentiated thyroid cancer. This study involved 41 thyroid cancer patients following total thyroidectomy. The uptake of thyroid remnants was repeatedly measured by a conventional probe system and beta-gamma exposure rate meter during the first week after a median of 75 MBq and 1.9 GBq of I-131 had been given for diagnostic and therapeutic purposes, respectively, 4 and 5 weeks postthyroidectomy. The mass of thyroid remnants was determined from two orthogonal pinhole gamma camera images assuming an ellipsoidal shape. Thyroid remnant absorbed dose was calculated by applying a Medical Internal Radiation Dose (MIRD) formalism. The pre-ablation absorbed dose of diagnostic I-131 (D) was found to be a decisive cause of thyroid stunning (TS). A non-linear logarithmic model TS=-7.9+17.4xln(D), r=0.62, p<0.01 was established, revealing the onset of TS for D=2 Gy, 50% TS for D=28 Gy and complete TS for 492 Gy. The cut-off target maximal absorbed dose-rate and cumulative absorbed dose of ablative I-131 in thyroid remnant were set at 2 Gy/h and 150 Gy, respectively, so as to be on the safe side. Thyroid stunning has been proven to be a real phenomenon evident in vivo if thyroid remnant is internally irradiated by very few gray. If diagnostic administration of I-131 prior to radioiodine therapy is necessary, radiation absorbed dose delivered pre-therapy by diagnostic I-131 should be <2 Gy or the ablative activity of I-131 should be appropriately corrected for the effect of thyroid stunning in order to deliver an amount of radiation sufficient for a complete ablation. It appears that any amount of diagnostic I-131 activity used for pre-ablation whole-body scanning will induce thyroid stunning, even if therapeutic administration of I-131 occurs within the following 2-3 days.

Izvorni jezik
Engleski

Znanstvena područja
Fizika, Elektrotehnika, Kliničke medicinske znanosti



POVEZANOST RADA


Ustanove:
Klinički bolnički centar Zagreb

Profili:

Avatar Url Mario Medvedec (autor)

Citiraj ovu publikaciju:

Medvedec, Mario
New dosimetric patient-based modelling of thyroid remnant stunning and ablation // Abstract Book of the 57th Annual Meeting of The Society of Nuclear Medicine (SNM) ; u: The Journal of Nuclear Medicine 51 (2010) (S2) ; 1567 / Schelbert, Heinrich R. (ur.).
Reston: The Society of Nuclear Medicine, 2010. str. 319P-319P (poster, međunarodna recenzija, sažetak, znanstveni)
Medvedec, M. (2010) New dosimetric patient-based modelling of thyroid remnant stunning and ablation. U: Schelbert, H. (ur.)Abstract Book of the 57th Annual Meeting of The Society of Nuclear Medicine (SNM) ; u: The Journal of Nuclear Medicine 51 (2010) (S2) ; 1567.
@article{article, author = {Medvedec, M.}, editor = {Schelbert, H.}, year = {2010}, pages = {319P-319P}, keywords = {thyroid cancer, dosimetry, thyroid stunning, thyroid remnant ablation}, title = {New dosimetric patient-based modelling of thyroid remnant stunning and ablation}, keyword = {thyroid cancer, dosimetry, thyroid stunning, thyroid remnant ablation}, publisher = {The Society of Nuclear Medicine}, publisherplace = {Salt Lake City, Utah, SAD} }
@article{article, author = {Medvedec, M.}, editor = {Schelbert, H.}, year = {2010}, pages = {319P-319P}, keywords = {thyroid cancer, dosimetry, thyroid stunning, thyroid remnant ablation}, title = {New dosimetric patient-based modelling of thyroid remnant stunning and ablation}, keyword = {thyroid cancer, dosimetry, thyroid stunning, thyroid remnant ablation}, publisher = {The Society of Nuclear Medicine}, publisherplace = {Salt Lake City, Utah, SAD} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE





Contrast
Increase Font
Decrease Font
Dyslexic Font